Skip Navigation
News and Publications
 
 
 
In This Section      
Print This Page

Conquest - Cervical Cancer

Making the Connection 2001-2008

Cervical Cancer

Date: April 20, 2010

CRF Investigator Connie Trimble


RESEARCH
Cervical cancer is caused by human papillomavirus (HPV) infection.
Precancerous lesions occur years before cancer and are easily detectable
through pap smears. Still cancer rates among women in Baltimore City and
Maryland’s Eastern Shore are three times the national average.

TRANSLATION
Researchers work to develop a vaccine that causes immune cells to recognize
and attack HPV and clear it out. Without the virus, the cancer cannot survive.

APPLICATION
With one shot in each arm, a 44-year-old woman, becomes the first patient to
receive Johns Hopkins-developed therapeutic HPV vaccine for cervical cancer.
Many patients have since been treated, and based on early promising research,
phase II trials are scheduled to begin in winter 2009.

Related Content

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer